content top

Vitreoretinal Surgery for Severe Retinal Capillary Hemangiomas in von Hippel-Lindau Disease: Two Cases

SCIENTIFIC POSTER Vitreoretinal Surgery for Severe Retinal Capillary Hemangiomas in von Hippel-Lindau Disease Two Cases by Bohdana Kalvodová, Zora Dubská, Magdalena Kováčová, Barbora Palasová, Czech Republic ABSTRACT Purpose: To evaluate results of 23-G pars plana vitrectomy for severe cases of retinal capillary hemangiomas (RCHs) in Von Hippel-Lindau (VHL) disease. Methods: Two eyes of 2 young patients (20 and 24 age) with...

Read More

Acute Zonal Occult Outer Retinopathy and Possibilities of Monitoring of Its Clinical Activity

ABSTRACT Purpose: Acute zonal occult outer retinopathy (AZOOR) is a rare disease of unknown etiology characterized by focal photoreceptor abnormalities. Aim of this project was to evaluate how to monitor its clinical activity. Methods: Retrospective analysis of patients with uveitis was conducted at Uveitis Centre in Prague and patients with diagnosis of AZOOR were identified. Clinical activity of AZOOR has been monitored by visual acuity,...

Read More

Dangerous Beauty …

RETINA PHOTO Dangerous Beauty … by Zora Dubská, E. Růžičková, T. Kučera, J. Dvořák, P. Sklenka, V. Filaová, P. Rajs, Czech Republic ABSTRACT Patient – woman with high myopy. Shortly before her cataract surgery of her only functional right eye, she had undergone a cosmetical procedure – the elongation of eyelashes. Five days after the surgery we found some fibrin around the pupil and in artificial mydriasis black...

Read More

Favourable Effect of Pars Plana Vitrectomy with Macugen and Lucentis Application as the Treatment of only One Eye with Hemorrhagic Glaucoma due to Central Retinal Vein Occlusion

Dubska, Z., Kalvodova, B., Diblik, P, Klímová, A Advantages: Positive morphological influence of medical treatment with anti-VEGF drugs in combination with PPV pars plana vitrectomy on the only one eye with haemorrhagic glaucoma due to ischemic central retinal vein occlusion CRVO is presented. Methods: Intravitreal injections of Macugen in total 3 times, Lucentis twice, panretinal photocoagulation 1 month after each application, PPV...

Read More
content top